Gritstone Oncology

Gritstone Oncology is a startup based in the United States. Its most recent tracked round is Series B. Brouky classifies it under Healthcare & Life Sciences. Brouky records 2 investors associated with the company.

Gritstone Oncology is a biotechnology company developing immunotherapies that leverage multi-specific antibodies to target tumor cells and stimulate the patient’s immune system to fight cancers such as lung, gastric, esophageal, head and neck, and cervical cancers.